Clone of Clone of BIOCON-1

ALZUMAb Has Been Approved For Psoriasis In India

By | Tue, 08/13/2013 - 14:12

The first homegrown Indian biologic drug, ALZUMAb, has hit the market in India for the treatment of moderate to severe plaque psoriasis.

Salmon

Omega-3-Filled Fish Can Prevent Rheumatoid Arthritis

By | Tue, 08/13/2013 - 12:07

By looking at tens of thousands of women over decades, researchers have found that regularly consuming fish heavy in omega-3 fatty acids can reduce the incidence of rheumatoid arthritis significantly.

GlaxoSmithKline

HIV Drug Tivicay from GlaxoSmithKline Gets FDA Approval

By | Mon, 08/12/2013 - 20:22

Tivicay is a new integrase inhibitor made by GlaxoSmithKline which was shown to be slightly better than Gilead's Atripla in reducing viral load in HIV infected patients after 48 weeks.

Bristol-Myers-Squibb-

BMS Depression Drug Failed To Show Benefit Compared to Other Current Drugs

By | Mon, 08/12/2013 - 19:31

An experimental drug from Bristol-Meyers Squibb and Albany Molecular Research, code-named BMS-820836, was shown to have no more effectiveness in treating untreatable depression compared to drugs currently on the market.

Clone of Clone of mental_illness_lead

5 Most Common Mental Disorders Linked To 1 Gene Variant

By | Mon, 08/12/2013 - 15:01

Using powerful genetic tools and a large pool of participants, researchers have found one genetic mutation common among five mental disorders.

Fata

Michigan Doctor Accused Of $35M In Medicare Fraud For Fake Cancer Diagnoses

By | Mon, 08/12/2013 - 11:36

Michigan doctor Farid Fata falsely billed $35 million to Medicare after treating patients with chemotherapy even if they didn't have cancer.

Cyclospora map

Cyclospora Outbreak Infects Over 500 In The US

By | Mon, 08/12/2013 - 09:25

Cyclospora, a foodborne parasite, has sickened 500 individuals in the United States. As of now, no one has become a fatal case.

Sanofi

Sanofi Under Investigation For Bribery Charges In China

By | Mon, 08/12/2013 - 09:07

Weeks after GlaxoSmithKline had four executives in China put in jail, Sanofi is being investigated for over a quarter-million dollars in bribes.

7d4e4499da97bf4d22a40430d450b22e

FDA Ups Charges To Pharma Companies For Generic Drug Reviews

By | Sat, 08/10/2013 - 10:30

Because of the significant cost in reviewing drug approval applications, the FDA is now charging generics makers more, but not that much more compared to drug developers who make brand name drugs.

idan8n-3-web

Boy With Rare Immune Disorder May Be Cured Thanks To Generosity Of Strangers

By | Fri, 08/09/2013 - 13:12

Idan Zablocki was diagnosed with a rare genetic immune disorder that leaves him unable to fight off simple infections.

allergan

India Revokes More Drug Patents, This Time On Allergan Eye Drugs

By | Fri, 08/09/2013 - 11:00

As the Indian government revokes even more drug patents, such as those on Allergan's eye drugs, it sets a dangerous precedent for the lack of protection afforded to drug developers.

Metabolic syndrome linked to memory loss in older people

Dementia Risk Linked To Blood Sugar Levels, Even In The Absence Of Diabetes

By | Wed, 08/07/2013 - 17:04

In people with high blood sugar levels, researchers found markedly high chances of developing dementia.

withdrawal pull out

'Withdrawal Method' Used By 31% Of Young Women; Why Pulling Out Doesn’t Effectively Prevent Pregnancy

By | Wed, 08/07/2013 - 16:23

Nearly one-third of young American women practice the withdrawal method to prevent pregnancy, yet over 20 percent of them get pregnant anyway.

pills

Seasonal Flu Vaccine Pill Currently In Human Testing, Goodbye Flu Shots!

By | Wed, 08/07/2013 - 11:43

Vaxart hopes to introduce a wide range of pill-based vaccines for diseases such as HPV and even the seasonal flu.

Drugs for Kidney Damage

Tolvaptan, Otsuka's Rare Kidney Disease Drug, Gets Shot Down By FDA Advisory Panel

By | Wed, 08/07/2013 - 10:35

Tolvaptan, which is already approved by the FDA for low blood sodium, has received a vote of no confidence from an advisory panel to the FDA.

Pages